Notably, the combination of HTRA1 methylation and stroke-related variables had robust power to distinguish stroke cases with onset time ≤ 1 year from controls (AUC = 0.76, 95% CI 0.67–0.84, Fig. 3D). This evidence concerns the gene HTRA1 and stroke disorder.